Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 15, 2017
Franklin Lakes, NJ (May 15, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
May 9, 2017BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room SettingNew Collaboration Aims to Provide Greater Visibility into Surgical Tracking and Loaner Tray Management
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company and UniteOR, Inc., announced today the integration between BD's IMPRESS(TM) instrument management system...
-
May 7, 2017
BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per share, and $2.25 billion of...
-
May 7, 2017
FRANKLIN LAKES, N.J., May 7, 2017 - BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has commenced registered offerings of $2.25 billion of common stock, par value $1.00 per...
-
May 5, 2017
FRANKLIN LAKES, N.J., May 5, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that, in connection with BD's previously announced acquisition of C. R. Bard, Inc. ("Bard"), BD...
-
May 2, 2017
Click on the links below to view results for 2017 Second Fiscal Quarter: View Document Online PDF File of BD 2017 Second Fiscal Quarter Results About BD BD is one of the largest global medical...
-
May 2, 2017New Plastic Molding Manufacturing Center of Excellence Coming to Columbus-East Plant
COLUMBUS, Neb., May 2, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it will invest $60 million to upgrade its Columbus-East...
-
Apr 27, 2017Mass spectrometry identification solution may help hospitals manage antimicrobial resistance more effectively
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global distribution of a complete portfolio of products for mass spectrometry that...
-
Apr 26, 2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has non-exclusively licensed its patented stochastic labelling technology to...
-
Apr 23, 2017Will Create Highly Differentiated Medical Technology Company Focused on Delivering Innovative Healthcare Solutions to Improve Clinical and Economic Outcomes Will Build on BD’s Leadership Position in Medication Management and Infection Prevention; Will Increase Opportunities in Innovative Fast-Growing Clinical Areas Financially Compelling Transaction; Immediately Accretive and Expected to Generate High Single-Digit Accretion to Adjusted EPS in Fiscal Year 2019 Tom Polen Named BD President
FRANKLIN LAKES, NJ and MURRAY HILL, NJ (April 23, 2017) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and C. R. Bard, Inc. (NYSE: BCR), a medical...
-
Apr 23, 2017
FRANKLIN LAKES, N.J., April 23, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Tom Polen, 43, as president...
-
Apr 6, 2017BD FACSVia(TM) System for Clinical Simplicity in Cell Analysis and Enumeration
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a...
-
Apr 6, 2017
FRANKLIN LAKES, N.J., April 6, 2017 – BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its second fiscal quarter 2017 earnings conference call...
-
Apr 4, 2017Expands Infusion Portfolio for Ambulatory, Home Care and Specialty Applications
FRANKLIN LAKES, N.J., April 4, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of...
-
Apr 3, 2017Visit booth #1115 to learn about the BD program focused on improving education, process and efficiency to impact patient safety
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its quality improvement program, BD "Power in Prevention" at the Association of...
-
Mar 28, 2017
WASHINGTON, March 28, 2017 – From the Mary’s Center in Washington, D.C., today BD (Becton, Dickinson and Company) (NYSE: BDX), in conjunction with Direct Relief and the National Association of...
-
Mar 22, 2017BD Showcases Solutions and Technologies to Improve Patient Safety Across the Continuum of Care at #EAHP2017
CANNES, March 22, 2017 - BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medication technology company, announced today the availability of its new IV Medication Safety Solution,...
-
Mar 1, 2017BD Awarded $100 Million Contract for Enterprise-Wide Automated Medication Dispensing Across 115 Military Health Facilities
FRANKLIN LAKES, N.J., MARCH 1, 2017 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it was awarded a contract worth up to $100...
Feb 22, 2017Health care providers and laboratories may be better equipped to test and treat patients during the flu seasonEffective Feb. 13, 2017, the Food and Drug Administration (FDA) has reclassified antigen based rapid influenza virus antigen detection systems (RIDTs) intended to detect influenza virus directly...
-
Feb 21, 2017BD Helping Build Healthy Communities(TM) Partnership Awarded for Helping Improve Care for Underserved Areas
A partnership among BD (Becton Dickinson and Company) (NYSE: BDX), Direct Relief and the National Association of Community Health Centers was selected as one of three winners for the Healthy10...
-
Feb 20, 2017BD Showcases its Leadership in Enterprise-wide Medication Management at #HIMSS2017
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will demonstrate its approach to a synchronized medication management technology platform aimed to help...
-
Feb 17, 2017
Franklin Lakes, NJ (February 17, 2017) - BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming...
-
Feb 16, 2017BD Aims to Improve the Management of Controlled Substances for Acute Care Facilities through Industry Alliance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a new alliance dedicated to help address the rising opioid crisis in acute care...
-
Feb 13, 2017Legacy Experience In Cell Sorting And Enrichment Combined With New Single- Cell And Library Prep Technology Offers Ideal Resolution Of Individual Cells At The Lowest Cost-Per-Answer
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an early access program for the BD Resolve(TM) Single-Cell Gene Expression platform...
-
Feb 2, 2017-- As reported, revenues of $2.922 billion decreased 2.1 percent, which reflects the divestiture of the Respiratory Solutions business.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.922 billion for the first fiscal quarter ended December 31,...